J&J Looks to Digital Surgery to Shape the Future of Orthopedic Procedures

article image

A conversation with Sharrolyn Josse, worldwide president of VELYS Digital Surgery & Capital at DePuy Synthes. Contributed by Johnson & Johnson’s DePuy Synthes division with an introduction by Mary Stuart.

Companies serving surgical specialties are generally dealing with hardware-dominated aspects of medicine—tools, screws, implants, and fasteners—so it has taken time for them to formulate the right digital health strategies. But many are on board now, with a new mission called digital surgery, whereby data has the potential to inform and improve every step of the surgical care pathway.

The definition of digital surgery is still fluid, with companies counting themselves members of the club if they offer surgical robots, AI-enhanced visualization, or other data analytics that can contribute to improved clinical and economic outcomes at one or several points along the surgical care continuum. But DePuy Synthes, the orthopedic company of Johnson & Johnson, is embracing the concept broadly; its VELYS Digital Surgery platform was created to address what happens before, during, and after surgery in orthopedics, the most hardware-heavy of all clinical specialties.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: